The similar result also found at Shang et al[9] study, for early stage HCC, osteopontin had a better sensitivity than AFP (75% vs 46%), but the specificity is lower than AFP (62% vs 93%). The gene discussed is AFP; the disease is hepatocellular carcinoma.